Bladder Cancer VL

Novel Gene Therapy Shows Efficacy and Tolerable Safety Profile for Patients with Treatment-Resistant Bladder Cancer - Trinity Bivalacqua

Details
Siamak Daneshmand hosts Trinity Bivalacqua to discuss advancements in non-muscle invasive bladder cancer, particularly focusing on newly FDA-approved therapies. Dr. Bivalacqua highlights the excitement surrounding the approval of new treatments for BCG unresponsive bladder cancer, including pembrolizumab and nadofaragene (ADSTILADRIN). He explains the significance of these developments, particular...

Successful Bladder Cancer Programs: What Should You Be Offering Your Patients Today and Tomorrow? "Presentation" - Daniel Saltzstein, Jonathan Henderson & Jay Krishnan

Details
Tom Jayram hosts a panel of experts to discuss advancements in bladder cancer treatment, emphasizing personalized therapies, clinical trials, and the importance of a comprehensive approach. They highlight the role of nephron-sparing techniques and new tests in improving traditional diagnostic methods. Biographies: Tom Jayram, MD, Urology Associates P.C, Nashville, TN Daniel Saltzstein, MD, Urology...

For Bladder Cancer Patients, New Hope From Immunotherapy Innovations from ESMO 2023 - Petros Grivas

Details
Ashish Kamat and Petros Grivas discuss recent advancements in metastatic bladder cancer treatments from ESMO Congress 2023. Key highlights include the CheckMate-901 and EV-302 trials. Dr. Grivas highlights the CheckMate-901 trial's success with the combination of gemcitabine, cisplatin, and nivolumab, which shows notable improvements in overall survival and progression-free survival with a managea...

Supportive Care in Bladder Cancer: A Deep Dive into Global Patient Needs and the Role of Healthcare Professionals - Bente Jensen & Alex Filicevas

Details
Ashish Kamat hosts Bente Jensen and Alex Filicevas to discuss key findings from a global survey on bladder cancer patient experiences and the supportive and complementary care needs of patients. This discussion is part of a four-part series in collaboration with UroToday and the World Bladder Cancer Patient Coalition. The World Bladder Cancer Patient Coalition serves as an international platform c...

Bladder Cancer's Impact on Daily Life and Employment: A Global Perspective - Lydia Makaroff & Lori Funk-Cirefice

Details
Ashish Kamat is joined by Lori Cirefice and Lydia Makaroff who discuss the findings of the Global World Bladder Cancer Patient Coalition Survey, focusing on the impact of bladder cancer on daily life and caregivers. The survey, which garnered nearly 1,200 responses from 45 countries, reveals significant financial and emotional strain on patients and their carers. Key findings include that 50% of p...

Quality of Life in Bladder Cancer: A Comparative Study on Cystectomy vs. Bladder Preservation - Vedang Murthy

Details
Vedang Murthy discusses his study on the quality of life in bladder cancer patients undergoing either cystectomy (surgery) or bladder preservation (chemo-radiotherapy). The study aims to fill a gap in understanding how each treatment impacts patients' quality of life, especially since recent research suggests that both treatments offer similar clinical outcomes. Surprisingly, the study found no si...

The Global Bladder Cancer Survey: A Strategic Analysis of Diagnosis and Care - Stephanie Demkiw & Lydia Makaroff

Details
Ashish Kamat discusses the World Bladder Cancer Patient Coalition's Bladder Cancer Patient and Carer Experience Survey with Stephanie Demkiw and Lydia Makaroff. The survey reveals that awareness of bladder cancer symptoms is low, with over half of the respondents unaware of the signs before diagnosis. Dr. Demkiw highlights that women are often diagnosed later than men and discusses the importance...

Global Insights into Bladder Cancer Care: A Comprehensive Survey by the World Bladder Cancer Patient Coalition - Patrick Hensley & Lydia Makaroff

Details
Ashish Kamat is joined by Pat Hensley and Lydia Makaroff, who share insights into patient experiences and treatment access. Drs. Hensley and Makaroff delve into the findings of the Global Bladder Cancer Patient and Care Experience survey, conducted by the World Bladder Cancer Patient Coalition. The survey, which garnered 1,198 respondents from diverse geographies, reveals that while 58% of patient...

Advancing Bladder Cancer Surveillance: The Impact of Flexible Blue Light Cystoscopy from the Nordic Registry - Karsten Zieger

Details
Zach Klaassen is joined by Karsten Zieger to talk about the results of an analysis from the Nordic registry evaluating the role of flexible blue light cystoscopy in the surveillance of non-muscle invasive bladder cancer. Dr. Zieger provides a comprehensive explanation of how blue light cystoscopy works. The method utilizes a photosensitizing agent, Hexvix in Europe or Cysview® in the U.S., that al...

New Research Sheds Light on Alternative Treatments for Node-Positive Bladder Cancer - Martin Swinton

Details
Leslie Ballas engages with Martin Swinton on his publication about bladder-sparing treatment options for clinically node-positive nonmetastatic bladder cancer. The study compares the efficacy of bladder-sparing treatment using radical dose radiotherapy to traditional radical cystectomy and finds no significant difference in overall survival rates. This supports bladder preservation as a viable alt...